NR2D-containing NMDA receptors mediate tissue plasminogen activator-promoted neuronal excitotoxicity (Q43243037)

17 November 2017

NR2D-containing NMDA receptors mediate tissue plasminogen activator-promoted neuronal excitotoxicity (English)

1 reference

17 November 2017

1 reference

1 reference

C Ali

6

0 references

author name string

A Baron

1

1 reference

17 November 2017

A Montagne

2

1 reference

17 November 2017

F Cassé

3

1 reference

17 November 2017

S Launay

4

1 reference

17 November 2017

E Maubert

5

1 reference

17 November 2017

D Vivien

7

1 reference

17 November 2017

13 November 2009

1 reference

Cell Death & Differentiation

17 November 2017

1 reference

17 November 2017

17

1 reference

17 November 2017

860-871

1 reference

17 November 2017

5

1 reference

https://scigraph.springernature.com/pub.10.1038/cdd.2009.172

17 November 2017

0 references

cites work

Tissue plasminogen activator contributes to the late phase of LTP and to synaptic growth in the hippocampal mossy fiber pathway.

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.172

Cleavage of proBDNF by tPA/plasmin is essential for long-term hippocampal plasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.172

Activity-dependent release of precursor nerve growth factor, conversion to mature nerve growth factor, and its degradation by a protease cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.172

Tissue-type plasminogen activator in the ischemic brain: more than a thrombolytic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.172

Tissue-type plasminogen activator crosses the intact blood-brain barrier by low-density lipoprotein receptor-related protein-mediated transcytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.172

The functional role of the second NPXY motif of the LRP1 beta-chain in tissue-type plasminogen activator-mediated activation of N-methyl-D-aspartate receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.172

Tissue-type plasminogen activator-mediated shedding of astrocytic low-density lipoprotein receptor-related protein increases the permeability of the neurovascular unit.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.172

Non-proteolytic neurotrophic effects of tissue plasminogen activator on cultured mouse cerebrocortical neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.172

The proteolytic activity of tissue-plasminogen activator enhances NMDA receptor-mediated signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.172

Arginine 260 of the amino-terminal domain of NR1 subunit is critical for tissue-type plasminogen activator-mediated enhancement of N-methyl-D-aspartate receptor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.172

Anti-NR1 N-terminal-domain vaccination unmasks the crucial action of tPA on NMDA-receptor-mediated toxicity and spatial memory.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.172

Ethanol-withdrawal seizures are controlled by tissue plasminogen activator via modulation of NR2B-containing NMDA receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.172

Modulation of NR2B-regulated contextual fear in the hippocampus by the tissue plasminogen activator system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.172

Tissue plasminogen activator mediates amyloid-induced neurotoxicity via Erk1/2 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.172

Tissue-type plasminogen activator: a multifaceted modulator of neurotransmission and synaptic plasticity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.172

MAPK cascade signalling and synaptic plasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.172

New targets for pharmacological intervention in the glutamatergic synapse

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.172

NMDA receptor trafficking in synaptic plasticity and neuropsychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.172

Role of distinct NMDA receptor subtypes at central synapses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.172

The dichotomy of NMDA receptor signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.172

NMDA receptor function: subunit composition versus spatial distribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.172

Structure-activity analysis of a novel NR2C/NR2D-preferring NMDA receptor antagonist: 1-(phenanthrene-2-carbonyl) piperazine-2,3-dicarboxylic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.172

Extrasynaptic NR2D-containing NMDARs are recruited to the synapse during LTP of NMDAR-EPSCs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.172

Preconditioning doses of NMDA promote neuroprotection by enhancing neuronal excitability

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.172

Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.172

NMDA receptor subunits have differential roles in mediating excitotoxic neuronal death both in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.172

NMDA di-heteromeric receptor populations and associated proteins in rat hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.172

Rapid hypoxia preconditioning protects cortical neurons from glutamate toxicity through delta-opioid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.172

Elevated synaptic activity preconditions neurons against an in vitro model of ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.172

N-methyl-D-aspartate receptor-mediated neuroprotection in cerebellar granule cells requires new RNA and protein synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.172

Nuclear Ca2+ and the cAMP response element-binding protein family mediate a late phase of activity-dependent neuroprotection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.172

Tissue-type plasminogen activator rescues neurones from serum deprivation-induced apoptosis through a mechanism independent of its proteolytic activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.172

Distinct NMDA receptor subpopulations contribute to long-term potentiation and long-term depression induction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.172

7 January 2021

NR2B and NR2D subunits coassemble in cerebellar Golgi cells to form a distinct NMDA receptor subtype restricted to extrasynaptic sites

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.172

7 January 2021

Depolarization or glutamate receptor activation blocks apoptotic cell death of cultured cerebellar granule neurons

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.172

7 January 2021

N-methyl-D-aspartate receptor blockade enhances neuronal apoptosis induced by serum deprivation

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.172

7 January 2021

Identifiers

DOI

10.1038/CDD.2009.172

1 reference

Dimensions Publication ID

17 November 2017

0 references

1 reference